Eisai Inc.
Eisai discovers, develops and markets pharmaceuticals in neurology and oncology-critical care. This site supports global partnerships, quality assurance and supply chain for the company.
Company Location
4130 Parklake Ave., Suite 500
Raleigh
NC
27612
Phone
County
Region
Company Details
Company type
Year founded
1987
Employment range in NC
US headquarters
New Jersey
Global headquarters
Japan
Primary site activity
All company activities
Potential end market(s)
Products on market
Aricept® (donepezil HCl) tablets;
Banzel® (rufinamide) tablets; Dayvigo® (lemborexant) tablets;
Fycompa® (perampanel) tablets;
Halaven® (eribulin mesylate) injection;
Lenvima® (Lenvatinib) tablets
Leqembi® (Lecanemab-irmb)
Banzel® (rufinamide) tablets; Dayvigo® (lemborexant) tablets;
Fycompa® (perampanel) tablets;
Halaven® (eribulin mesylate) injection;
Lenvima® (Lenvatinib) tablets
Leqembi® (Lecanemab-irmb)